期刊文献+

非小细胞肺癌患者外周血调节性T细胞表达及意义 被引量:11

Expression of regulatory T cells in the peripheral blood and its clinical significance in patients with non-small cell lung cancer
原文传递
导出
摘要 目的探讨CD4+CD25+,CD8+CD28-调节性T细胞及其亚群表型CD45RO在非小细胞肺癌(non-small cell lung cancer,NSCLC)患者外周血中表达及其与NSCLC临床病理及手术的关系。方法采用流式细胞仪检测40例NSCLC患者和20例对照外周血中CD4+CD25+,CD8+CD28-,CD8+CD28+T细胞亚群比率,并对其亚群表型CD45RO进行检测。结果 NSCLC组CD4+CD25+,CD4+CD25+CD45RO+,CD8+CD28-细胞亚群比率较对照组明显升高(P<0.05);CD8+CD28+细胞亚群比率较对照组明显降低(P<0.01);NSCLC组手术后CD4+CD25+细胞亚群比率较术前明显降低(P<0.01),CD8+CD28+细胞亚群比率较术前明显升高(P<0.01);外周血调节性T细胞水平与NSCLC临床病理无相关性(P>0.05)。结论 CD4+CD25+,CD8+CD28-和CD8+CD28+T细胞亚群比率的改变可能与肺癌免疫耐受和抗肿瘤能力下降有关;手术治疗可下调患者机体的肿瘤免疫耐受,改善患者抗肿瘤免疫功能。 Objective To investigate the changes of CD4^+ CD25^+ and CD8^+ CD28^- regulatory T cells in the peripheral blood in patients with non-small cell lung cancer (NSCLC), and their relationship with clinical pathological changes and operation therapy. Methods The expressions of the CD4^+ CD25^+ , CD8^+ CD28^- T cells, CD8^+ CD28^+ T cells and CD45RO in the peripheral blood were detected with flow cytometry in 40 patients with NSCLC before and after operation and 20 healthy controls. Results Compared with control group, the proportions of CD4^+ CD25^+ , CD4^+ CD25^+ CD45RO^+ and CD8^+ CD28^- T cells increased significantly(P〈 0.05), while the proportion of CD8^+ CD28^+ T cells decreased significantly (P〈0.01) in NSCLC group. The proportion of CD4+ CD25^+ cells was significantly lower (P〈 0.01) and the proportion of CD8^+ CD28^+ T cells was significantly higher (P〈0.01) in NSCLC patients after operation than that before operation. The proportion of regulatory T cells was not correlated with elinieopathologie changes of NSCLC (P〉 0.05). Conclusion The changes of CD4^+ CD25^+, CD8^+ CD28^- and CD8^+ CD28^+ T cells might be correlated with the immuno tolerance and the decreased cellular immunity function in NSCLC. Operation could down regulate the immuno tolerance and improve anticancer immunity function in NSCLC patients.
出处 《中华实用诊断与治疗杂志》 2012年第7期645-647,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 首都医科大学基础临床科研合作课题(10JL56)
关键词 非小细胞肺癌 免疫耐受 调节性T细胞 流式细胞术 Non-small cell lung cancer immuno tolerance regulatory T cell flow cytometry
  • 相关文献

参考文献11

  • 1Li C H, Kuo W H, Chang W C, etal. Activation of regulatory T cells instigates functional down-regulation of cytotoxic T lymphoeytes in human breast cancer[J]. Immunol Res, 2011,51 (1) :71-79.
  • 2Yamamoto T, Yanagimoto H, Satoi S, et al. Circulating CD4+ CD25+ regulatory T cells in patients with pancreatic cancer[J]. Pancreas,2012,41(3):409-415.
  • 3Han Y, Wu J, Bi L, et al. Malignant B cells induce the conversion of CD4CD25 T ceils to regulatory T cells in B cell non Hodgkin lymphoma[J]. PLoS One,2011,6(12):e28649.
  • 4Lee W C, Wu T J, Chou H S, et al. The impact of CD4(+) CD25(+) T cells in the tumor microenvironment of hepatocellular carcinoma[J]. Surgery,2012,151(2) :213-222.
  • 5Fenoglio D, Ferrera F, Fravega M, et al. Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28 regulatory T cells[J]. Hum Immunol, 2008,69 (11) :745-750.
  • 6Filaci G, Fenoglio D, Fravega M, et al. CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxie functions infiltrate human cancers[J]. J Immunol, 2007,179 (7):4323-4334.
  • 7Karagóz B, Bilgi O, Gtimiis M, et al. CD8+ CD28 cells and CD4+ CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients [J]. Med Oncol, 2010, 27 (1):29-33.
  • 8Hotta K, Sho M, Fujimoto K, et al. Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma[J]. Br J Cancer, 2011,105(8) : 1191-1196.
  • 9沈玉光,许金良,杨宗林,赵婷茹.流式细胞术测肺癌患者外周血T细胞亚群及其与临床病理的关系[J].实用诊断与治疗杂志,2006,20(2):101-102. 被引量:22
  • 10徐红,毛一香,张学光,王庆才.晚期消化道肿瘤患者化疗前后T细胞亚群的变化[J].癌症,2008,27(4):418-424. 被引量:27

二级参考文献49

  • 1师国珍,李旬源,郭跃信.外照射加参麦注射液治疗肺癌的免疫功能测定[J].实用诊断与治疗杂志,2005,19(7):496-496. 被引量:6
  • 2沈玉光,许金良,杨宗林,赵婷茹.流式细胞术测肺癌患者外周血T细胞亚群及其与临床病理的关系[J].实用诊断与治疗杂志,2006,20(2):101-102. 被引量:22
  • 3李广太,张士伟,宋学茹,钟述猷,刘政,尉建华,杨金富,米保香.妇科肿瘤患者外周血淋巴细胞亚群研究[J].中国肿瘤临床,1996,23(7):504-508. 被引量:17
  • 4Hung K, Hayashi R, Lafond-Walker A, et al. The central role of CD4(+) T cells in the antitumor immune response[J]. J Exp Med, 1998,188(12): 2357.
  • 5Goedegebuure P T, Eberlein, The role of CD4^+ tumor-infiltrating lymphoeytes in human solid tumors [J]. Immunol Res, 1995,14(2):119.
  • 6Rosenberg S A, Yang J C, Schwartzentruber D J, et al.Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma[J]. Nat Med, 1998, 4(3): 321.
  • 7Advani S H, Kutty P M, Gopal R, et al. Immunity in oesophageal carcinoma[J]. J Surg Oncol, 1983, 24(4): 268.
  • 8Olsen G N, Gangemi J D, Bronchoalveolar layage and the immunology of primary lung cancer [J].Chest, 1985,87(5) : 677.
  • 9Mitropoulos D, Alamanis C, Deliveliotis C, et al. T-lymphocyte subsets in the peripheral blood of patients with renal cell carcinoma[J]. Acta Urol Belg, 1995, 63(3):21.
  • 10Khaled A R, Durum S K. The role of cytokines in lymphocyte homeostasis [J]. Biotechniques, 2002,Oct;suppl:40.

共引文献53

同被引文献127

引证文献11

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部